These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9371523)

  • 1. Renal cell carcinoma: recent progress and future directions.
    Mulders P; Figlin R; deKernion JB; Wiltrout R; Linehan M; Parkinson D; deWolf W; Belldegrun A
    Cancer Res; 1997 Nov; 57(22):5189-95. PubMed ID: 9371523
    [No Abstract]   [Full Text] [Related]  

  • 2. Adoptive cellular therapy.
    Hoffman DM; Gitlitz BJ; Belldegrun A; Figlin RA
    Semin Oncol; 2000 Apr; 27(2):221-33. PubMed ID: 10768601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in immunotherapy for kidney cancer.
    Ball MW; Allaf ME; Drake CG
    Discov Med; 2016 Apr; 21(116):305-13. PubMed ID: 27232516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines in renal cell carcinoma.
    Kübler H; Vieweg J
    Semin Oncol; 2006 Oct; 33(5):614-24. PubMed ID: 17045091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of renal carcinoma: new genetic strategies.
    Junien C; Béroud C; Fournet JC
    Adv Nephrol Necker Hosp; 1997; 26():81-106. PubMed ID: 8922127
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy for renal cell carcinoma.
    Belldegrun A; Figlin R; Danella J; deKernion J
    Semin Urol; 1992 Feb; 10(1):23-7. PubMed ID: 1565900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current immunotherapeutic strategies in renal cell carcinoma.
    Amato RJ
    Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5T4 as a target for immunotherapy in renal cell carcinoma.
    Elkord E; Shablak A; Stern PL; Hawkins RE
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1705-9. PubMed ID: 19954280
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of surgical malignancies.
    Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
    Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy: its potential applications in the treatment of renal-cell carcinoma.
    Jaffee EM; Pardoll DM
    Semin Oncol; 1995 Feb; 22(1):81-91. PubMed ID: 7855623
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapeutic approaches for renal cancer.
    Pizza G; de Vinci C; Viza D
    Folia Biol (Praha); 2002; 48(5):167-81. PubMed ID: 12448765
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biological response modifiers and urological cancer].
    Ohmori H; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1992 Jun; 83(6):850-6. PubMed ID: 1501395
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic treatment for renal cell carcinoma: an overview.
    Swanson DA
    Prog Clin Biol Res; 1990; 350():201-25. PubMed ID: 2201044
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal cancer: Genetic directed therapy.
    Loughlin KR
    Urol Oncol; 2009; 27(2):130. PubMed ID: 19285229
    [No Abstract]   [Full Text] [Related]  

  • 16. [Specific immunotherapy with cancer vaccines].
    Yamana H; Itoh K
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1477-88. PubMed ID: 11015990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivity of human GM-CSF gene therapy in metastatic renal cell carcinoma and prostate cancer.
    Simons JW
    Hinyokika Kiyo; 1997 Nov; 43(11):821-2. PubMed ID: 9436029
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.
    Passalacqua R; Buti S; Tomasello G; Longarini R; Brighenti M; Dalla Chiesa M
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1459-72. PubMed ID: 17069530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in the treatment of metastatic kidney cancer?
    Mancuso A; Sternberg CN
    BJU Int; 2005 Jun; 95(9):1171-80. PubMed ID: 15892796
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cell therapy for renal cell carcinoma].
    Kawai K
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1745-51. PubMed ID: 12402424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.